DMRA · Damora Therapeutics, Inc. · Congressional Trades
$23.22
-1.08 (-4.44%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 4, 2026
Market Cap
$1.44B
Shares
61.90M
Volume · Nov 20
643.39K
Avg daily vol (3M)
577.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
115 filings
112 filers
Visit website
Investor relations